Arakawa Chemical Industries : Consolidated Financial Results for the Fiscal Year Ended March 31, 2023

Consolidated Financial Results for the Fiscal Year Ended March 31, 2023

[Japanese GAAP]

May 11, 2023

Company name: ARAKAWA CHEMICAL INDUSTRIES, LTD.

Stock exchange listing: Tokyo Stock Exchange

Code number: 4968

URL: https://www.arakawachem.co.jp/en/

Representative: Takashi Une, Representative Director and President

Contact: Toru Nobuhiro, Managing Director and General Manager of Administrative H.Q.

Phone: [phone]

Scheduled date of Annual General Meeting of Shareholders: June 20, 2023

Scheduled date of commencing dividend payments: June 21, 2023

Scheduled date of filing securities report: June 20, 2023

Availability of supplementary explanatory materials on annual financial results: Available

Schedule of annual financial results briefing session: Scheduled

(for institutional investors/securities analysts)

(Amounts of less than one million yen are rounded down.)

1. Consolidated Financial Results for the Fiscal Year Ended March 31, 2023 (April 1, 2022 - March 31, 2023)

(1) Consolidated Operating Results		(% indicates changes from the previous corresponding period.)
		Net sales		Operating profit	Ordinary profit	Profit attributable
			to owners of parent
	Fiscal year ended	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%
	March 31, 2023	79,431	(1.3)	(2,907)	-	(2,687)	-	(4,941)	-
	March 31, 2022	80,515	14.1	3,304	1.4	3,566	(2.3)	1,502	(30.7)

(Note) Comprehensive income: Fiscal year ended March 31, 2023: ¥ (4,668) million [-%] Fiscal year ended March 31, 2022: ¥ 3,425 million [(40.7)%]

	Basic earnings	Diluted earnings	Return on	Ordinary profit	Operating profit
	per share	per share	equity	to total assets	to net sales
Fiscal year ended	Yen	Yen	%	%	%
March 31, 2023	(249.08)	-	(8.7)	(2.3)	(3.7)
March 31, 2022	75.75	-	2.6	3.2	4.1

(Reference) Equity in earnings of affiliated companies: Fiscal year ended March 31, 2023: ¥ - million Fiscal year ended March 31, 2022: ¥ - million

(2) Consolidated Financial Position

Total assets

Net assets

Equity ratio

Net assets per share

Millions of yen

Millions of yen

%

Yen

As of March 31, 2023

119,035

56,509

45.4

2,726.08

As of March 31, 2022

117,739

62,578

50.3

2,983.23

(Reference) Equity: As of March 31, 2023: ¥ 54,082 million

As of March 31, 2022: ¥ 59,184 million

(3) Consolidated Cash Flows

Cash flows from

Cash flows from

Cash flows from

Cash and cash

equivalents

operating activities

investing activities

financing activities

at end of period

Fiscal year ended

Millions of yen

Millions of yen

Millions of yen

Millions of yen

March 31, 2023

(575)

(6,046)

6,666

9,286

March 31, 2022

3,989

(7,401)

4,927

9,250

2. Dividends

Annual dividends

Total

Ratio of

Payout ratio

dividends to

1st

2nd

3rd

Year-

dividends

quarter-

quarter

quarter

Total

(consolidated)

net assets

(annual)

end

-end

-end

end

(consolidated)

Yen

Yen

Yen

Yen

Yen

Millions of yen

%

%

Fiscal year ended

-

24.00

-

24.00

48.00

952

63.4

1.6

March 31, 2022

Fiscal year ended

-

24.00

-

24.00

48.00

952

-

1.7

March 31, 2023

Fiscal year ending

March 31, 2024

-

24.00

-

24.00

48.00

-

(Forecast)

3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2024 (April 1, 2023 - March 31, 2024)

(% indicates changes from the previous corresponding period.)

							Profit		Basic earnings
	Net sales	Operating profit	Ordinary profit		attributable to
			per share
							owners of parent
	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%	Yen
First half	40,000	(4.1)	(2,000)	-	(2,100)	-	(1,800)	-	(90.73)
(cumulative)
Full year	83,000	4.5	(1,800)	-	(2,000)	-	(1,800)	-	(90.73)

* Notes:

1. Changes in significant subsidiaries during the fiscal year under review: None (Changes in specified subsidiaries resulting in changes in scope of consolidation) Newly included: - companies (Company name)
   Excluded: - companies (Company name)
2. Changes in accounting policies, changes in accounting estimates and retrospective restatement
3. 1. Changes in accounting policies due to the revision of accounting standards: Yes
   2. Changes in accounting policies other than 1) above: None
   3. Changes in accounting estimates: None
   4. Retrospective restatement: None
4. Total number of issued shares (common shares)
5. 1. Total number of issued shares at the end of the year (including treasury shares):

March 31, 2023:	20,652,400 shares
March 31, 2022:	20,652,400 shares
2) Total number of treasury shares at the end of the year:
March 31, 2023:	813,491 shares
March 31, 2022:	813,391 shares
3) Average number of shares during the year:
Fiscal year ended March 31, 2023:	19,838,976 shares
Fiscal year ended March 31, 2022:	19,839,024 shares

(Reference) Summary of Non-consolidated Financial Results

1. Non-consolidated Financial Results for the Fiscal Year Ended March 31, 2023 (April 1, 2022 - March 31, 2023)

(1) Non-consolidated Operating Results			(% indicates changes from the previous corresponding period.)
		Net sales				Operating profit	Ordinary profit	Profit
	Fiscal year ended	Millions of yen		%		Millions of yen	%	Millions of yen	%	Millions of yen	%
	March 31, 2023	48,080		0.4		(1,246)	-	629	(78.2)	(5,654)	-
	March 31, 2022	47,900	10.8		1,098	133.8	2,892	42.8	2,232	15.4
		Basic earnings		Diluted earnings
		per share			per share
	Fiscal year ended	Yen				Yen
	March 31, 2023	(285.04)				-
	March 31, 2022	112.54				-

(2) Non-consolidated Financial Position

	Total assets	Net assets	Equity ratio	Net assets per share
	Millions of yen	Millions of yen	%	Yen
As of March 31, 2023	88,930	43,160	48.5	2,175.56
As of March 31, 2022	88,651	50,178	56.6	2,529.28

(Reference) Equity: As of March 31, 2023: ¥43,160 million As of March 31, 2022: ¥50,178 million

• These consolidated financial results are outside the scope of audit by certified public accountants or an audit firm.
• Explanation on the proper use of financial results forecast and other special notes

Forward-looking statements, including financial results forecasts, contained in this document are based on information currently available to the Company and certain assumptions deemed reasonable. Therefore, these

statements do not constitute a guarantee that they will be realized. Actual results may differ materially from these statements due to various factors.